About Us

Our flagship product, Abagen®, is a clinically proven anti-inflammatory bioactive peptide derived from Australian abalone. Developed through years of research, Abagen® harnesses the power of the ocean to support joint health and alleviate inflammation, backed by both in vivo and in vitro studies.

Our Mission

Our mission is to create high-quality, sustainable health solutions inspired by marine life. By unlocking the therapeutic potential of marine peptides, we strive to bring innovative, science-backed wellness products to people around the world.

Meet the Team

  • Joe Milani

    CEO / FOUNDER

    LinkedIn

  • Jordan Tan

    PRODUCT MANAGER

    LinkedIn

  • Tess Milani

    INNOVATION & BRAND MANAGER

    LinkedIn

  • Hannah Robertson

    MARKETING MANAGER

Our team consists of experts in marine biotechnology, research, and sustainable product development. From our scientists to our operational staff, every member of Abagen®, is passionate about delivering excellence. We pride ourselves on our commitment to quality, innovation, and sustainability.

Follow Us on LinkedIn

Founding Story.

Southern Ocean Biotech was founded in 2017 by Joseph Milani with a vision to leverage the therapeutic properties of abalone in health applications.

In partnership with CSIRO, Australia’s leading national science agency, and the Fisheries Research and Development Corporation (FRDC), we developed Abagen®, an innovative bioactive peptide with potent anti-inflammatory effects.